Fundz

Mydecine Innovations Group Inc. reported raising $628,000 in an initial SEC Form D filing, from an offering of $1.39 Million

PRIVATEJun 15, 2022$628.1K of $1.4M raised

Amount Raised

$628,000

$628,000 sold, per SEC Form D (first sale Jun 15, 2022)

Round Type

Seed

VancouverOtherBiotechnologyHealth Care

Quick answer

Mydecine Innovations Group raised $628,000 in a Seed round, dated June 15, 2022. Mydecine Innovations Group is based in Vancouver, British Columbia, Canada.

How much did Mydecine Innovations Group raise?
Mydecine Innovations Group raised $628,000 in a Seed round on June 15, 2022.
What does Mydecine Innovations Group do?
Mydecine Innovations Group is a forefront biotechnology company dedicated to revolutionizing mental health and addiction treatment.
Where is Mydecine Innovations Group based and how big is it?
Mydecine Innovations Group is based in Vancouver, British Columbia, Canada.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Mydecine Innovations Group that raised within 45 days of this round, from Fundz verified event records.

  • Medcura raised $3.2M on July 29, 2022.
  • TendoNova raised $215K (Seed) on July 29, 2022.
  • Theriva Biologics raised $3M (Seed) on July 29, 2022.
  • Core Biogenesis raised $11M (Funding Round) on July 28, 2022.
  • Vicinitas Therapeutics raised $65M (Series A) on July 28, 2022.
  • Suvera raised $6.5M (Funding Round) on July 28, 2022.

Who to call at Mydecine Innovations Group, and when

A new round usually means Mydecine Innovations Group is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mydecine Innovations Group raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mydecine Innovations Group, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mydecine Innovations Group. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mydecine Innovations Group

Location

Vancouver, British Columbia, Canada

About

Mydecine Innovations Group is a forefront biotechnology company dedicated to revolutionizing mental health and addiction treatment. The company aims to increase physicians' access to serotonin-modulating medicine and develop innovative medications for target indications with high mortality rates.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mydecine Innovations Group raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mydecine Innovations Group's next move

See what Strategic adds

Mydecine Innovations Group raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.